header_about2b@2x.jpg
 

A results-driven platform

PBM Capital is a healthcare-focused investment firm that invests in companies in the pharmaceutical and life sciences industries. We partner with exceptional scientists, engineers and entrepreneurs who have developed game-changing technologies that can improve and save lives.

Building a company is hard.  We bring proven operational capabilities and expertise to enable our portfolio companies to develop revolutionary products. We know how to build winning companies.

 
 
 
 
Banner_about@2x.jpg
 

Our entrepreneurial heritage starts with our founder, Paul Manning, who built PBM Products from scratch with less than $1 million invested and grew it to the world’s leading provider of private label infant formula, supplying products to over 50,000 retail stores. PBM Products was sold to Perrigo, a publicly listed pharmaceutical company, for over $800 million. After this transaction, Paul formed PBM Capital in 2010 to provide dedicated capital to healthcare investments.

PBM Capital currently has several platform operating companies developing life-changing pharmaceutical and biological products.

Since 2016, three of our portfolio companies — AveXis (subsequently acquired by Novartis), Dova Pharmaceuticals and Verrica Pharmaceuticals — have successfully completed initial public offerings.

We look for companies that are run by entrepreneurs whose aspirations are consistent with our thesis and who we trust and admire.